
|
Partners
ManRex
Winnipeg-based ManRex has been designing and marketing medication delivery systems around the world for over thirty years. Their innovative approaches to medication delivery have changed the way pharmacists and nurses distribute medications while helping them achieve their goal of more time for patient care.
ManRex is Intelligent Hospital Systems exclusive sales agent in Canada, where their extensive experience in the Canadian marketplace and long-term relationship with Canadian hospitals will ensure that our flagship product RIVA (Robotic IV Automation) is successfully introduced to the Canadian marketplace.
For more information about ManRex Ltd, please visit www.manrex.com
www.manrex.com
Saint Boniface General Hospital
St. Boniface General Hospital (SBGH) and Western Life Sciences (and its predecessor Keystone Technologies) have been partners since 1999. SBGH is the owner of the technology behind RIVA, the Robotic IV Automation System that Western Life Sciences has been developing since 2004 through its investee IH Systems. IH Systems has licensed the technology from SBGH in order to develop and commercialize the RIVA System.
www.sbgh.mb.ca
Western Life Sciences
The Western Life Sciences Venture Fund LP is a $45 Million venture capital fund established to create, acquire, and develop early and later stage human bio/medical technology companies. The fund is managed by Lombard Life Sciences.
WLS is a the majority owner of IH Systems and has made a substantial financial investment in the company. It is a strong supporter of the company and will continue to provide the necessary financial and managerial support.
www.westernlifesciences.com
Lombard Life Sciences
Lombard Life Sciences was founded with a mandate to fund early stage commercialization of life science discoveries and develop innovative new products.
The past decade's exponential growth in biotechnology has created a gap between new discoveries and the translation of that information into products for prevention, detection and treatment of human disease.
Universities and research institutes have a strong track record of basic science discoveries. While basic research grants are available through governments and various agencies, few opportunities exist to obtain funding for commercialization of basic research discoveries, to help them move from the bench to the bedside.
Lombard Life Sciences is here to bridge that gap.
www.lombardlifesciences.com
|
|

|

|
|